Laster I - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Bispecific T-Cell Engaging Antibodies Against MUC16 Demonstrate Efficacy Against Ovarian Cancer in Monotherapy and in Combination With PD-1 and VEGF Inhibition.

Yeku OO, Rao TD, Laster I, Kononenko A, Purdon TJ, Wang P, Cui Z, Liu H, Brentjens RJ, Spriggs D. Yeku OO, et al. Among authors: laster i. Front Immunol. 2021 Apr 14;12:663379. doi: 10.3389/fimmu.2021.663379. eCollection 2021. Front Immunol. 2021. PMID: 33936101 Free PMC article.

Targeting galectin-3 with a high-affinity antibody for inhibition of high-grade serous ovarian cancer and other MUC16/CA-125-expressing malignancies.

Stasenko M, Smith E, Yeku O, Park KJ, Laster I, Lee K, Walderich S, Spriggs E, Rueda B, Weigelt B, Zamarin D, Rao TD, Spriggs DR. Stasenko M, et al. Among authors: laster i. Sci Rep. 2021 Feb 12;11(1):3718. doi: 10.1038/s41598-021-82686-3. Sci Rep. 2021. PMID: 33580170 Free PMC article.

"Kneeling" buses and other aids simplify travel for the elderly and handicapped.

Laster I Jr. Laster I Jr. Geriatrics. 1977 Jul;32(7):34-7. Geriatrics. 1977. PMID: 141393 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Search Page

Filters